PB2080: EFFICACY AND SAFETY OF BENDAMUSTINE-BASED REGIMENS AS FIRST-LINE TREATMENT FOR INDOLENT B-CELL NON-HODGKIN LYMPHOMA: A PROSPECTIVE, MULTICENTER, REAL-WORLD STUDY IN CHINA
S. Li,
S.-J. Wen,
J. Ma
Affiliations
S. Li
1 Department of Lymphoma, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi
S.-J. Wen
1 Department of Lymphoma, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi
J. Ma
2 Department of Hematology & Oncology, Harbin Institute of Hematology & Oncology, Harbin, China
